SB 152 – Colorado
Introduced: 2018 Status: Inactive / Dead
PROHIBIT PRICE GOUGING ON PRESCRIPTION DRUGS: Prohibits a pharmaceutical manufacturer or wholesaler from price gouging on sales of essential off-patent or generic drugs; makes the practice of price gouging a deceptive trade practice under the ‘Colorado …
SB 2038 – Texas
Introduced: 2021 Status: Enacted
Relating to prices and fees charged by certain freestanding emergency medical care facilities, including prices and fees charged during a declared state of disaster; providing administrative penalties. This bill would address price gouging by freestanding …
SB 208 – West Virginia
Introduced: 2020 Status: Enacted
AN ACT to amend and reenact §46A-6J-2 and §46A-6J-3 of the Code of West Virginia, 1931, as amended, all relating to the protection of consumers from price gouging and unfair pricing practices during and shortly …
SB 223 – Virginia
Introduced: 2018 Status: Inactive / Dead
PRESCRIPTION DRUGS: PRICE GOUGING PROHIBITED. Prohibits unconscionable price increases in the price of essential off-patent or generic drugs, authorizes the Secretary of Health and Human Resources to designate drugs as essential drugs, and establishes an …
SB 415 – Indiana
Introduced: 2019 Status: Inactive / Dead
Essential off-patent or generic drugs. Prohibits a manufacturer or a wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug. Provides that the office of the secretary of …
Download
SB 5251 – Washington
Introduced: 2019 Status: Inactive / Dead
CONCERNING PRESCRIPTION DRUG COST TRANSPARENCY. The office shall compile and analyze the data submitted by issuers, pharmacy benefit managers, and pharmacy services administrative organizations under sections 3, 4, and 5 of this act and prepare an …
SB 5292 – Washington
Introduced: 2019 Status: Inactive / Dead
CONCERNING PRESCRIPTION DRUG COST TRANSPARENCY. The office shall compile and analyze the data submitted by issuers, pharmacy benefit managers, and pharmacy services administrative organizations under sections 3, 4, and 5 of this act and prepare an …
SB 5371 – Washington
Introduced: 2019 Status: Inactive / Dead
PROTECTING CONSUMERS AND PURCHASERS FROM EXCESSIVE INCREASES IN INSULIN DRUG PRICES. If a drug manufacturer increases the wholesale acquisition cost of an insulin drug by ten percent at any one time or in the aggregate in …
SB 577 (see companion bill HB 4554) – West Virginia
Introduced: 2020 Status: Inactive / Dead
Relating to insurance coverage for insulin. The purpose of this bill is to limit the amount that an insured person is required to pay for his or her insulin prescription to $100 per 30-day supply.
SB 5995 (see companion bill HB 2556) – Washington
Introduced: 2018 Status: Inactive / Dead
GENERIC PRESCRIPTION DRUG PRICES: Protects consumers and purchasers from excessive increases in generic prescription drug prices, requires a drug manufacture to use a price increase notification form when there is an increase in the wholesale acquisition …
SB 650 – West Virginia
Introduced: 2019 Status: Inactive / Dead
Protecting consumers from price gouging after state of emergency: A BILL to amend and reenact §46A-6J-2 of the Code of West Virginia, 1931, as amended, relating to the protection of consumers from price gouging and …
SB 688 – New Hampshire
Introduced: 2020 Status: Inactive / Dead
Relative to the pricing of generic prescription drugs. This bill requires the commissioner of the Department of Health and Human Services to notify the Department of Justice of certain price increases for essential off-patent or …
SB 791 – Connecticut
Introduced: 2021 Status: Inactive / Dead
AN ACT CONCERNING PRICE GOUGING IN THE EVENT OF A PUBLICLY DECLARED EMERGENCY. To prevent against price gouging in the event of a publicly declared emergency.
SB 866 (see companion bill HB 1941) – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to unconscionable prices charged by certain health care facilities for medical care.
SB 874 (see companion bill AB 1046) – Wisconsin
Introduced: 2018 Status: Inactive / Dead
This bills requires that no manufacturer or wholesale distributor may sell or offer to sell an essential off-patent or generic drug at a price that results in price gouging. Under the bill, price gouging means …
SB 900 (see companion bill HB 5690) – Michigan
Introduced: 2018 Status: Inactive / Dead
PROHIBIT MANUFACTURERS FROM CHARGING EXCESSIVE PRICES OR UNCONSCIONABLE INCREASES IN WHOLESALE ACQUISITION COSTS: A manufacturer of prescription drugs that is engaged in the conduct of trade or commerce shall not charge an excessive price for …